In patients with IDC abundant NDRG2 mRNA expression showed a significant association (Pearson r: 0.2274, P<0.001) with a high breast cancer 21-gene recurrence score predicting poor prognosis in tamoxifen-treated, node-negative breast cancer [26] (Fig 3A and 3B). Here, NDRG2 is linked to breast carcinoma.